JAZZ Financial Facts
Selling, general and administrative: 124.37MNet income (loss): 87.15M
See Full Income Statement
See Full Balance Sheet
Jazz Pharmaceuticals, Inc. (JAZZ) Earnings
|
Expand Research on JAZZ
| Next EPS Date | 8/5/26 | EPS Growth Rate | +174.8% |
|---|---|---|---|
| Average EPS % Beat Rate | +17.5% | Revenue Growth Rate | +6.2% |
| Average % Move 1-Wk after EPS | +3.6% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/5/26  |
Q226 | N/A | $6.17 | N/A | N/A | $1.11B | = | N/A | N/A | ||
| 5/5/26 | Q126 | $6.34 | $4.62 | +$1.72 | $1.07B | $981.08M | = |  | | Details | |
| 2/24/26 | Q425 | $6.64 | $6.39 | +$0.25 | $1.2B | $1.16B | = | | | Details | |
| 11/5/25 | Q325 | $8.13 | $5.93 | +$2.20 | $1.13B | $1.11B | = | | | Details | |
| 8/5/25 | Q225 | -$8.25 | -$7.62 | -$0.63 | $1.05B | $1.04B | = | | | Details | |
| 5/6/25 | Q125 | $1.68 | $4.81 | -$3.13 | $897.84M | $983.86M | = | | | Details | |
| 2/25/25 | Q424 | $6.60 | $5.79 | +$0.81 | $1.1B | $1.06B | = | | | Details | |
| 11/6/24 | Q324 | $6.61 | $5.50 | +$1.11 | $1.06B | $1.04B | = | | | Details |
